File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s40778-018-0147-3
- Scopus: eid_2-s2.0-85056320147
- WOS: WOS:000461119800007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Mini Review: Application of Human Mesenchymal Stem Cells in Gene and Stem Cells Therapy Era
Title | Mini Review: Application of Human Mesenchymal Stem Cells in Gene and Stem Cells Therapy Era |
---|---|
Authors | |
Keywords | Autoimmune Cell therapy Delivery tool Genetic modification Mesenchymal stem cells |
Issue Date | 2018 |
Publisher | Springer. The Journal's web site is located at http://www.springer.com/life+sciences/cell+biology/journal/40778 |
Citation | Current Stem Cell Reports, 2018, v. 4, p. 327-337 How to Cite? |
Abstract | Purpose of Review Mesenchymal stem cells (MSCs) have abilities of self-renewal and multi-lineage differentiation. MSCs can evade immune rejection following allogeneic transplantation setting due to their downregulation of HLA Class II antigen. Therefore, we review the current understanding of using MSCs or MSC-conditioned media as treatment for various diseases. Recent Findings (1) MSCs regulate the balance of Th17/Treg cells in autoimmune disease models, which is associated with complex interactions among different pro- or anti-inflammation cytokines. (2) With the nature of MSCs migrating to multiple tissues under various homing signals, we also found MSCs are widely used as cell vehicles for gene or chemokine delivery. Summary MSCs or MSC-conditioned media therapies have been explored with advanced techniques. However, it still requires further investigations on (1) how MSCs respond to various microenvironments and (2) how to isolate, purify and expand enough MSCs ex vivo. Keywords Mesenchymal stem cells Cell therapy Autoimmune Paracrine Genetic modification Delivery tool |
Persistent Identifier | http://hdl.handle.net/10722/266022 |
ISSN | 2023 Impact Factor: 2.3 2023 SCImago Journal Rankings: 0.794 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Deng, R | - |
dc.contributor.author | Law, HY | - |
dc.contributor.author | Shen, J | - |
dc.contributor.author | Chan, GCF | - |
dc.date.accessioned | 2018-12-17T02:16:33Z | - |
dc.date.available | 2018-12-17T02:16:33Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | Current Stem Cell Reports, 2018, v. 4, p. 327-337 | - |
dc.identifier.issn | 2198-7866 | - |
dc.identifier.uri | http://hdl.handle.net/10722/266022 | - |
dc.description.abstract | Purpose of Review Mesenchymal stem cells (MSCs) have abilities of self-renewal and multi-lineage differentiation. MSCs can evade immune rejection following allogeneic transplantation setting due to their downregulation of HLA Class II antigen. Therefore, we review the current understanding of using MSCs or MSC-conditioned media as treatment for various diseases. Recent Findings (1) MSCs regulate the balance of Th17/Treg cells in autoimmune disease models, which is associated with complex interactions among different pro- or anti-inflammation cytokines. (2) With the nature of MSCs migrating to multiple tissues under various homing signals, we also found MSCs are widely used as cell vehicles for gene or chemokine delivery. Summary MSCs or MSC-conditioned media therapies have been explored with advanced techniques. However, it still requires further investigations on (1) how MSCs respond to various microenvironments and (2) how to isolate, purify and expand enough MSCs ex vivo. Keywords Mesenchymal stem cells Cell therapy Autoimmune Paracrine Genetic modification Delivery tool | - |
dc.language | eng | - |
dc.publisher | Springer. The Journal's web site is located at http://www.springer.com/life+sciences/cell+biology/journal/40778 | - |
dc.relation.ispartof | Current Stem Cell Reports | - |
dc.subject | Autoimmune | - |
dc.subject | Cell therapy | - |
dc.subject | Delivery tool | - |
dc.subject | Genetic modification | - |
dc.subject | Mesenchymal stem cells | - |
dc.title | Mini Review: Application of Human Mesenchymal Stem Cells in Gene and Stem Cells Therapy Era | - |
dc.type | Article | - |
dc.identifier.email | Deng, R: rxdeng@hku.hk | - |
dc.identifier.email | Law, HY: lawanna@hkucc.hku.hk | - |
dc.identifier.email | Shen, J: shenjg@hku.hk | - |
dc.identifier.email | Chan, GCF: gcfchan@hku.hk | - |
dc.identifier.authority | Shen, J=rp00487 | - |
dc.identifier.authority | Chan, GCF=rp00431 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1007/s40778-018-0147-3 | - |
dc.identifier.scopus | eid_2-s2.0-85056320147 | - |
dc.identifier.hkuros | 296303 | - |
dc.identifier.volume | 4 | - |
dc.identifier.spage | 327 | - |
dc.identifier.epage | 337 | - |
dc.identifier.isi | WOS:000461119800007 | - |
dc.publisher.place | Germany | - |
dc.identifier.issnl | 2198-7866 | - |